A multicenter, randomized controlled study of the clinical efficacy of intravenous peramivir versus oseltamivir against influenza A and B virus infection in high-risk patients
Latest Information Update: 16 May 2016
At a glance
- Drugs Peramivir (Primary) ; Oseltamivir
- Indications Influenza A virus infections; Influenza B virus infections
- Focus Therapeutic Use
- 21 Sep 2015 Primary endpoint has not been met. (Duration of symptoms), according to an abstract presented at the Joint 55th Interscience Conference on Antimicrobial Agents and Chemotherapy and 28th International Congress of Chemotherapy
- 21 Sep 2015 Results presented at the Joint 55th Interscience Conference on Antimicrobial Agents and Chemotherapy and 28th International Congress of Chemotherapy
- 04 Jun 2014 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.